Cancer Therapy
Toxicity and pharmacokinetics of NK911 elucidated
Published in Cancer Weekly, January 18th, 2005
"NK911 is a novel supramolecular nanocarrier designed for the enhanced delivery of doxorubicin (DXR) and is one of the successful polymer micelle systems to exhibit an efficient accumulation in solid tumors in mice," oncologists in Japan explained.
Y. Matsumura and colleagues at the National Cancer Center in Chiba conducted a study "to define the maximum-tolerated dose (MTD) and dose-limiting toxicities (DLTs) of NK911 and to evaluate its pharmacokinetic profile in man."
"NK911 was given intravenously...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2005-01-18)
More Articles from Cancer Weekly
- Breast Cancer
Cancer detected by screening mammography associated with less toxic therapy - Cancer Genetics
BRCA1 mutation prevalence in ovarian tumors is low in Norway - Cancer Therapy
Riddelliine mutagenicity different in liver endothelial and parenchymal cells - Colon Cancer
Chemotherapy useful for liver metastases from colorectal cancer - Hepatocellular Carcinoma
Dendritic cells elicit T-cell-mediated immune responses to HCA587 protein - Acute Myeloid Leukemia
Genes with prognostic value identified in childhood AML with FLT3 mutations - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
